Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

WeedMD signs LOI to create Consumer-Centric Product Portfolio with acquisition of CannTx

WeedMD signs LOI to create Consumer-Centric Product Portfolio with acquisition of CannTx

WeedMD Inc. (CVE: WMD – OTCQX: WDDMF) Interim CEO George Scorsis joined Steve Darling to share details the company has signed an LOI to acquire craft cultivator CannTx Life Sciences in an all-stock deal. Scorsis telling Proactive CannTx, which in Guelph, Ontario, is a highly regarded cultivator that specializes in tissue culture and micropropagation techniques, agricultural research, craft cultivation, and processing of new cannabis products such as rosin and hash. He also said this will now allow WeedMD to boast one of the most comprehensive genetic banks in the industry.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK